Suzanne L. Topalian

Cancer immunotherapy researcher associated with clinical development of PD-1 pathway blockade. Suzanne L. Topalian is a person tracked in this database because they are connected to cancer-related books, media, protocols, organizations, clinical care, advocacy, research, education, products, or patient support. Review linked records and source notes for role, credentials, perspective, claims, and relevance before relying on the information.

Suzanne L. Topalian is a physician-scientist whose clinical research helped establish the therapeutic importance of PD-1 pathway blockade in cancer.